Cephalexin
NDC 68289-008
Product Information
Cephalexin is a ANDA-approved product labeled by Jazeera Pharmaceutical. This medication is used to treat a wide variety of bacterial infections. It is supplied as a product. This product entry covers the primary NDC 68289-008 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 68289-008?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CEPHALEXIN ANHYDROUS (UNII: 5SFF1W6677)
- CEPHALEXIN ANHYDROUS (UNII: 5SFF1W6677) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SUCROSE (UNII: C151H8M554)
- XANTHAN GUM (UNII: TTV12P4NEE)
- CITRIC ACID (UNII: 2968PHW8QP)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- SACCHARIN SODIUM (UNII: SB8ZUX40TY)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 309110 - cephalexin 125 MG in 5 mL Oral Suspension
- RxCUI: 309110 - cephalexin 25 MG/ML Oral Suspension
- RxCUI: 309110 - cefalexin 25 MG/ML Oral Suspension
- RxCUI: 309110 - cephalexin 125 MG per 5 ML Oral Suspension
- RxCUI: 309113 - cephalexin 250 MG in 5 mL Oral Suspension
* Please review the full disclaimer at the bottom of this page.